eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | atrial fibrillation |
| Comorbidity | C0018824|valvular heart disease |
| Sentences | 8 |
| PubMedID- 21287469 | New procedure for treatment of atrial fibrillation in patients with valvular heart disease. |
| PubMedID- 22263119 | We reportthat results of cox-maze iv procedure for treatment of chronic afib associated with valvular heart disease is 80.7% of success rate at 6months and 3.3% recurrence rate afterwards. |
| PubMedID- 23465222 | Objectives: the aim of this study was to determine whether altered calreticulin expression and distribution contribute to the pathogenesis of atrial fibrillation (af) associated with valvular heart disease (vhd). |
| PubMedID- 20550616 | Background: the purpose of this study is to evaluate the efficacy of atrial fibrillation (af) ablation in patients with moderate valvular heart disease (vhd). |
| PubMedID- 23631185 | [atrial fibrillation concomitant with valvular heart disease]. |
| PubMedID- 22547769 | Aims: the aim of this study was to determine whether altered expression and distribution of calcium- and integrin-binding protein-1 (cib1) is involved in the pathogenesis of different types of patients with atrial fibrillation (af) associated with valvular heart disease (vhd). |
| PubMedID- 26261514 | Therefore, we hypothesized that synd4 shedding was also involved in the inflammatory response in atrial fibrillation patients with valvular heart disease. |
| PubMedID- 24431682 | The indications were valvular heart disease with valve replacement, atrial fibrillation, or thrombus in 60 % patients; chronic deep vein thrombosis (dvt) in 7 % patients; thrombophilia in 9.1 % patients; recurrent pregnancy losses in 18 % patients; and dvt prophylaxis in 5.5 % patients. |
Page: 1